l General Information |
Product Name | FRAX597 |
General description | FRAX597 is a potent, ATP-competitive inhibitor of group I PAKs. |
Synonym | 6-[2-chloro-4-(1,3-thiazol-5-yl)phenyl]-8-ethyl-2-[4-(4-methylpiperazin-1-yl)anilino]pyrido[2,3-d]pyrimidin-7-one |
Purity | ≥98.0%(HPLC) | CAS Number | 1286739-19-2 |
Formula | C29H28ClN7OS | Molecular Weight | 558.10 |
Suitability | BioReagent, suitable for cell culture, etc. |
l Physical and Chemical Information |
Appearance | Solid |
Solubility(25℃) | DMSO | ≥10mg/mL(warmed) |
Ethanol | ~1mg/mL |
Water | Insoluble |
l Biological Information |
Biochem/Physiol
Actions | FRAX597 is a potent, ATP-competitive inhibitor of group I PAKs with IC50 of 8 nM, 13 nM, and 19 nM for PAK1, PAK2, and PAK3, respectively. |
l Storage |
Storage temp. | -20℃ |
l Precautions and Disclaimer |
This product is for R&D use only, not for drug, household, or other uses. |
l References |
1. http://www.drugbank.ca 2. https://ncit.nci.nih.gov 3. https://www.ncbi.nlm.nih.gov |